<sup>99m</sup>Tc-labelled glucosamine in the assessment of systemic sclerosis inflammatory lung disease: a novel inexpensive investigative tool with predictive value.

Englert, H; Richards, B L; Angelides, S; Kumar, V; Spencer, D; Howe, G; Manolios, N

^99mTc-labelled glucosamine in the assessment of systemic sclerosis inflammatory lung disease: a novel inexpensive investigative tool with predictive value.

Englert, H; Richards, B L; Angelides, S; Kumar, V; Spencer, D; Howe, G; Manolios, N.

Afiliación

Englert H; Staff Specialist Blacktown Hospital, Sydney, Australia.
Richards BL; Visiting Medical Officer Westmead Hospital, Sydney, NSW, Australia.
Angelides S; Staff Specialist Royal Prince Alfred Hospital, Sydney, NSW, Australia.
Kumar V; Nuclear Medicine Dept, Westmead Hospital, Westmead, Sydney, Australia. socrates.angelides@health.nsw.gov.au.
Spencer D; Faculty Medical Health, University of Sydney, Sydney, NSW, Australia. socrates.angelides@health.nsw.gov.au.
Howe G; Nuclear Medicine Dept, Westmead Hospital, Westmead, Sydney, Australia.
Manolios N; Faculty Medical Health, University of Sydney, Sydney, NSW, Australia.

Ann Nucl Med ; 35(10): 1157-1166, 2021 Oct.

Article en En | MEDLINE | ID: mdl-34319547

Asunto(s)

Glucosamina; Enfermedades Pulmonares Intersticiales; Adulto; Humanos; Persona de Mediana Edad; Proyectos Piloto; Pruebas de Función Respiratoria

Palabras clave

Glucosamine; Glucosamine scan; Inflammatory lung disease; Interstitial lung disease; Nuclear scan; Systemic sclerosis

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Enfermedades Pulmonares Intersticiales / Glucosamina Tipo de estudio: Prognostic_studies / Risk_factors_studies / Screening_studies Límite: Adult / Humans / Middle aged Idioma: En Revista: Ann Nucl Med Asunto de la revista: MEDICINA NUCLEAR Año: 2021 Tipo del documento: Article País de afiliación: Australia

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google